 |
Protein C concentrate |
|---|---|
| Trade Name | Ceprotin |
| Orphan Indication | For replacement therapy in congenital protein C deficiency for the prevention and treatment of thrombosis, pulmonary emboli, and purpura fulminans |
| USA Market Approval | USA |
| USA Designation Date | 1992-06-23 00:00:00 |
| Sponsor | Baxalta US, Inc.;One Baxter Way;West Lake Village, California, 91362 |
